Daewon Pharmaceutical Co., Ltd. (KRX:003220)

Daewon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	279,063	305,427	331,930	393,197	342,999	380,715
Market Cap Growth	-4.98%	-7.99%	-15.58%	14.64%	-9.91%	13.65%
Enterprise Value	425,533	434,054	418,509	453,068	412,231	412,859
Last Close Price	13020.00	14250.00	15327.52	17998.08	15224.81	16689.90
PE Ratio	30.46	21.49	13.88	12.31	49.08	21.58
Forward PE	22.86	9.77	9.77	9.77	9.77	9.77
PS Ratio	0.46	0.51	0.63	0.82	0.97	1.23
PB Ratio	1.00	1.07	1.26	1.58	1.57	1.79
P/TBV Ratio	1.29	1.27	1.37	1.74	1.77	1.88
P/FCF Ratio	7.14	-	8.41	21.36	18.73	27.98
P/OCF Ratio	3.48	10.17	6.42	14.89	15.30	15.26
PEG Ratio	0.32	0.49	0.49	0.49	0.49	0.49
EV/Sales Ratio	0.70	0.73	0.79	0.95	1.16	1.34
EV/EBITDA Ratio	9.81	9.28	8.40	7.28	11.11	10.41
EV/EBIT Ratio	19.55	16.27	12.98	10.56	21.36	17.22
EV/FCF Ratio	10.89	-	10.61	24.62	22.52	30.35
Debt / Equity Ratio	0.65	0.66	0.55	0.47	0.57	0.25
Debt / EBITDA Ratio	4.24	4.00	2.93	1.87	3.34	1.32
Debt / FCF Ratio	4.63	-	3.70	6.33	6.77	3.86
Asset Turnover	1.04	1.10	1.10	1.09	0.93	0.93
Inventory Turnover	2.79	2.86	2.76	3.01	2.69	2.49
Quick Ratio	0.55	0.62	0.56	0.89	1.07	0.93
Current Ratio	1.12	1.19	1.15	1.62	1.77	2.09
Return on Equity (ROE)	1.68%	3.68%	9.15%	13.13%	3.07%	8.25%
Return on Assets (ROA)	2.27%	3.06%	4.19%	6.07%	3.16%	4.52%
Return on Capital (ROIC)	2.83%	3.78%	5.20%	7.58%	3.97%	5.76%
Return on Capital Employed (ROCE)	5.60%	7.00%	9.90%	13.20%	5.90%	8.60%
Earnings Yield	2.93%	4.65%	7.21%	8.12%	2.04%	4.63%
FCF Yield	14.00%	-1.58%	11.88%	4.68%	5.34%	3.57%
Dividend Yield	2.30%	2.10%	-	-	1.27%	0.93%
Payout Ratio	78.76%	44.75%	30.69%	12.90%	44.93%	28.54%
Buyback Yield / Dilution	-0.94%	-1.47%	0.98%	-3.09%	0.58%	1.06%
Total Shareholder Return	1.37%	0.63%	0.98%	-3.09%	1.85%	1.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.